Hes1 potentiates T cell lymphomagenesis by up-regulating a subset of Notch target genes

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Dudley, Darryll D ^a   Wang, Hong Cheng ^a   Sun, Xiao Hong ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MYC PROTEIN; NOTCH RECEPTOR; NOTCH3 RECEPTOR; PROTEIN BHLH E; PROTEIN KINASE LCK; PROTEIN LD1; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HES1 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CD25+ T LYMPHOCYTE; CD4+ CD8+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; GENE TARGETING; LYMPHOMAGENESIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; THYMUS LYMPHOMA; TRANSGENE; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; FLOW CYTOMETRY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

MUS; MUS MUSCULUS;

ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DNA PRIMERS; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; LYMPHOMA, T-CELL; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; UP-REGULATION;

EID: 68949215697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006678     Document Type: Article

References (54)

1. Kruisbeek AM, Haks MC, Carleton M, Michie AM, Zuniga-Pflucker JC, et al. (2000) Branching out to gain control: how the pre-TCR is linked to multiple functions. Immunol Today 21: 637-644.
2. Michie AM, Zuniga-Pflucker JC (2002) Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. Semin Immunol 14: 311-323.
3. von Boehmer H (1994) Positive selection of lymphocytes. Cell 76: 219-228.
4. Artavanis-Tsakonas S, Matsuno K, Fortini ME (1995) Notch signaling. Science 268: 225-232.
5. Schroeter EH, Kisslinger JA, Kopan R (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393: 382-386.
6. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, et al. (1995) Signalling downstream of activated mammalian Notch. Nature 377: 355-358.
7. Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, et al. (2006) c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 20: 2096-2109.
8. Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, et al. (2006) NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A 103: 18261-18266.
9. Tanigaki K, Honjo T (2007) Regulation of lymphocyte development by Notch signaling. Nat Immunol 8: 451-456.
10. Balciunaite G, Ceredig R, Rolink AG (2005) The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential. Blood 105: 1930-1936.
11. Sambandam A, Maillard I, Zediak VP, Xu L, Gerstein RM, et al. (2005) Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 6: 663-670.
12. Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, et al. (1999) Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10: 547-558.
13. Rothenberg EV, Moore JE, Yui MA (2008) Launching the T-cell-lineage developmental programme. Nat Rev Immunol 8: 9-21.
14. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, et al. (1999) Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11: 299-308.
15. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, et al. (1996) Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 183: 2283-2291.
16. Paroush Z, Finley RL Jr, Kidd T, Wainwright SM, Ingham PW, et al. (1994) Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins. Cell 79: 805-815.
17. Nuthall HN, Husain J, McLarren KW, Stifani S (2002) Role for Hes1-induced phosphorylation in Groucho-mediated transcriptional repression. Mol Cell Biol 22: 389-399.
18. Tomita K, Hattori M, Nakamura E, Nakanishi S, Minato N, et al. (1999) The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev 13: 1203-1210.
19. Kawamata S, Du C, Li K, Lavau C (2002) Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene 21: 3855-3863.
20. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, et al. (1991) TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66: 649-661.
21. Aster JC, Pear WS (2001) Notch signaling in leukemia. Curr Opin Hematol 8: 237-244.
22. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, et al. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1: 75-87.
23. Chen Q, Cheng JT, Taub R, Schneider N, Buchanan G, et al. (1990) The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 9: 415-424.
24. Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, et al. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271.
25. Reschly EJ, Spaulding C, Vilimas T, Graham WV, Brumbaugh RL, et al. (2006) Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. Blood 107: 4115-4121.
26. Dumortier A, Jeannet R, Kirstetter P, Kleinmann E, Sellars M, et al. (2006) Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 26: 209-220.
27. Weerkamp F, Luis TC, Naber BA, Koster EE, Jeannotte L, et al. (2006) Identification of Notch target genes in uncommitted T-cell progenitors: No direct induction of a T-cell specific gene program. Leukemia 20: 1967-1977.
28. Maillard I, Fang T, Pear WS (2005) Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 23: 945-974.
29. Kim D, Peng XC, Sun XH (1999) Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol Cell Biol 19: 8240-8253.
30. Yan W, Young AZ, Soares VC, Kelley R, Benezra R, et al. (1997) High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol 17: 7317-7327.
31. Rezaie AR, Fiore MM, Neuenschwander PF, Esmon CT, Morrissey JH (1992) Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Protein Expr Purif 3: 453-460.
32. Garvin AM, Abraham KM, Forbush KA, Farr AG, Davison BL, et al. (1990) Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int Immun 2: 173-180.
33. Akazawa C, Sasai Y, Nakanishi S, Kageyama R (1992) Molecular characterization of a rat negative regulator with a basic helix-loop-helix structure predominantly expressed in the developing nervous system. J Biol Chem 267: 21879-21885.
34. Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S (1992) Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev 6: 2620-2634.
35. Ceredig R (1988) Differentiation potential of 14-day fetal mouse thymocytes in organ culture. Analysis of CD4/CD8-defined single-positive and double-negative cells. J Immunol 141: 355-362.
36. Paterson DJ, Williams AF (1987) An intermediate cell in thymocyte differentiation that expresses CD8 but not CD4 antigen. J Exp Med 166: 1603-1608.
37. Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, et al. (2000) Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J 19: 3337-3348.
38. Morrow MA, Mayer EW, Perez CA, Adlam M, Siu G (1999) Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages. Mol Immunol 36: 491-503.
39. O'Neil J, Billa M, Oikemus S, Kelliher M (2001) The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice. Oncogene 20: 3897-3905.
40. Krebs LT, Deftos ML, Bevan MJ, Gridley T (2001) The Nrarp gene encodes an ankyrin-repeat protein that is transcriptionally regulated by the notch signaling pathway. Dev Biol 238: 110-119.
41. Chiang MY, Xu L, Shestova O, Histen G, L'heureux S, et al. (2008) Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 118: 3181-3194.
42. Fowlkes BJ, Robey EA (2002) A reassessment of the effect of activated Notch1 on CD4 and CD8 T cell development. J Immunol 169: 1817-1821.
43. Baer R (1993) TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. Semin Cancer Biol 4: 341-347.
44. O'Neil J, Shank J, Cusson N, Murre C, Kelliher M (2004) TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 5: 587-596.
45. Nie L, Xu M, Vladimirova A, Sun XH (2003) Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J 22: 5780-5792.
46. Nie L, Perry SS, Zhao Y, Huang J, Kincade PW, et al. (2008) Regulation of lymphocyte development by cell-type-specific interpretation of notch signals. Mol Cell Biol 28: 2078-2090.
47. Reynaud-Deonauth S, Zhang H, Afouda A, Taillefert S, Beatus P, et al. (2002) Notch signaling is involved in the regulation of Id3 gene transcription during Xenopus embryogenesis. Differentiation 69: 198-208.
48. Talora C, Campese AF, Bellavia D, Pascucci M, Checquolo S, et al. (2003) Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep 4: 1067-1072.
49. Engel I, Johns C, Bain G, Rivera RR, Murre C (2001) Early thymocyte development is regulated by modulation of E2A protein activity. J Exp Med 194: 733-745.
50. Qi Z, Sun XH (2004) Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes. Mol Cell Biol 24: 7313-7323.
51. Kim D, Xu M, Nie L, Peng XC, Jimi E, et al. (2002) Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/ NF-kappaB activities. Immunity 16: 9-21.
52. Pan L, Hanrahan J, Li J, Hale LP, Zhuang Y (2002) An analysis of T cell intrinsic roles of E2A by conditional gene disruption in the thymus. J Immunol 168: 3923-3932.
53. Selten G, Cuypers HT, Zijlstra M, Melief C, Berns A (1984) Involvement of cmyc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J 3: 3215-3222.
54. Lewis WH, Michalopoulos EE, Williams DL, Minden MD, Mak TW (1985) Breakpoints in the human T-cell antigen receptor alpha-chain locus in two T-cell leukaemia patients with chromosomal translocations. Nature 317: 544-546.